市場調查報告書

全球介入神經放射學設備市場:各產品類型、用途、地區 - 成長,趨勢,預測(2018年∼2023年)

Global Interventional Neurology Devices Market - Segmented by Product Type, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 660543
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
全球介入神經放射學設備市場:各產品類型、用途、地區 - 成長,趨勢,預測(2018年∼2023年) Global Interventional Neurology Devices Market - Segmented by Product Type, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)
出版日期: 2018年04月01日內容資訊: 英文 112 Pages
簡介

全球介入神經放射學設備市場,預計從2018年到2023年以7.5%的年複合成長率發展。亞太地區市場,由於神經疾病的罹患率的上升與放鬆管制預計有顯著的成長。

本報告提供全球介入神經放射學設備市場調查,市場概要,各產品類型、用途、地區的市場規模的變化與預測,市場趨勢,市場佔有率,成長要素、阻礙因素以及市場機會、課題分析,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 成長要素,阻礙因素,市場機會,課題

  • 市場成長要素
    • 神經疾病的發生率的上升
    • 對微創治療的需求高漲
    • 對神經治療的研究開發費的增加
    • 老年人的增加
  • 市場阻礙因素
    • 設備的成本高
    • 嚴格的償付方案
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各產品類型
    • 球囊擴張式腦血管成形術 & 支架置入系統
    • 腦血栓消除設備
    • 動脈瘤線圈栓塞術 & 栓塞術用設備
    • 微導管
    • 導管導引線
  • 各用途
    • 動脈狹窄
    • 缺血性中風
    • 腦動脈瘤
    • 靜脈狹窄
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • 合併及收購分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要企業

  • Abbott
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic, Inc.
  • Merit Medical Systems.
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • WL Gore & Associates.
  • 其他企業

第10章 市場未來展望

目錄
Product Code: 54384

The global interventional neurology devices market is expected to register a CAGR of 7.5% during the forecast period, (2018 -2023). The Asia-Pacific is anticipated to grow significantly during the forecast period, owing to rising incidence of neurological diseases and less stringent regulatory scenario.

Increasing Incidence of Neurological Disorders

According to a study published in the April 2017, in the Journal of the Annals of Neurology, the most common neurological diseases cost USD 789 billion, in 2014, in the United States, and is expected to grow in the future, due to the rising elderly populations. According to data from the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC), 84,767 people died from Alzheimer's disease in 2013. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases. Globally, an estimated 2.4 million people are diagnosed with epilepsy each year. The increasing incidences of neurological disorders is driving the market. Additionally, the increasing demand for minimally invasive treatment, increasing R&D investment for neurotherapies from key players, and rising elderly population is likely to drive the market growth for interventional neurology devices, globally.

Stringent Regulatory Guidelines

Food and Drug Administration (FDA) strictly regulates the approval of medical devices depending on their class. There is relatively few class I neurological devices. Majority of the neurological devices are classified under Class II and Class III. Some of the Class I devices include ventricular needles and anvils used to form skull plates. Class II devices include neurostimulators, aneurysm clips, and blood clot retrievers. Examples of Class III devices are deep brain stimulators and medical devices for the treatment of brain tumors. Approval of class III medical devices is complicated and requires clinical trials. The time taken for the trials can 36 months or more, depending on the extent of clinical trials and additional information that FDA might request. European Union has recently taken steps to strengthen its regulatory approval process significantly, and this is expected to delay approvals in Europe. The delay in regulatory approvals and high cost of interventional devices are the major challenges faced by the companies involved in the manufacture of neurological devices.

North America to Dominate the Market

North America is expected to hold the largest share of neurovascular devices market during the forecast period. The factors, such as significant adoption of neurovascular devices among neurosurgeons, favorable reimbursement scenario, the presence of established key players in the region, and huge investment in R&D are driving the growth of the North American interventional neurology market.

Key Developments in the Market:

January 2018: Medtronic received US FDA clearance for Riptide aspiration system intended for use in the revascularization of patients with acute ischaemic stroke secondary to large intracranial vessel occlusive disease

July 2017: Johnson & Johnson Medical Devices Companies recently introduced CERENOVUS, its new neurovascular business.

Major Players: ABBOTT, B. BRAUN MELSUNGEN AG, PENUMBRA, INC., BOSTON SCIENTIFIC CORPORATION, JOHNSON & JOHNSON, MEDTRONIC, INC., MERIT MEDICAL SYSTEMS., STRYKER CORPORATION, TERUMO CORPORATION AND WL GORE & ASSOCIATES., amongst others.

Reasons to Purchase the Report:

Current and future global interventional neurology devices market outlook, in the developed and emerging markets

Analysis of various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness the fastest growth during the forecast period

Identify the latest developments, market shares, and strategies employed by the major market players

3 months analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report:

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Product and Services
    • 5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Increasing Incidence of Neurological Disorders
    • 6.1.2 Risng Demand for Minimally Invasive Treatment
    • 6.1.3 Increasing R&D Investment for Neurotherapies
    • 6.1.4 Rising Elderly Population
  • 6.2 Market Restraints
    • 6.2.1 High Cost of Devices
    • 6.2.2 Stringent Regulatory Scenario
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 By Product Type
    • 7.1.1 Cerebral Balloon Angioplasty and stenting Systems
      • 7.1.1.1 Carotid Artery Stents
      • 7.1.1.2 Embolic Protection Systems
    • 7.1.2 Neurothrombectomy Devices
    • 7.1.3 Aneurysm Coiling and Embolization Devices
    • 7.1.4 Micro-catheters
    • 7.1.5 Guidewires
  • 7.2 By Application
    • 7.2.1 Artery Stenosis
    • 7.2.2 Ischemic Strokes
    • 7.2.3 Brain Aneurysm
    • 7.2.4 Vein Stenosis
    • 7.2.5 Others
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 United States
      • 7.3.1.2 Canada
      • 7.3.1.3 Mexico
    • 7.3.2 Europe
      • 7.3.2.1 France
      • 7.3.2.2 Germany
      • 7.3.2.3 United Kingdom
      • 7.3.2.4 Italy
      • 7.3.2.5 Spain
      • 7.3.2.6 Rest Of Europe
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 China
      • 7.3.3.2 Japan
      • 7.3.3.3 India
      • 7.3.3.4 Australia & New Zealand
      • 7.3.3.5 South Korea
      • 7.3.3.6 Rest of Asia-Pacific
    • 7.3.4 Middle East & Africa
      • 7.3.4.1 GCC
      • 7.3.4.2 South Africa
      • 7.3.4.3 Rest of the Middle East & Africa
    • 7.3.5 South America
      • 7.3.5.1 Brazil
      • 7.3.5.2 Argentina
      • 7.3.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers and Acquisition Analysis
  • 8.2 Agreements, Collaborations, and Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 Abbott
  • 9.2 B. Braun Melsungen AG
  • 9.3 Boston Scientific Corporation
  • 9.4 Johnson & Johnson
  • 9.5 Medtronic, Inc.
  • 9.6 Merit Medical Systems.
  • 9.7 Penumbra, Inc.
  • 9.8 Stryker Corporation
  • 9.9 Terumo Corporation
  • 9.10 W. L. Gore & Associates.
  • 9.11 List Not Exhaustive

10. Future of the Market